| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| EXELExelixis, Inc. | 11.81B | 44.06 | 15.85 | 6.98% | 29.63% | 31.37% | 7.49% | 0.08 |
| INCYIncyte Corporation | 20.1B | 101.27 | 15.80 | 21.22% | 25.03% | 24.9% | 6.74% | 0.01 |
| GMABGenmab A/S | 18.13B | 29.44 | 15.36 | 30.67% | 46.8% | 114.25% | 6.6% | 0.03 |
| SNDXSyndax Pharmaceuticals, Inc. | 1.89B | 21.71 | -5.82 | -279.31% | -269.93% | 1.20 | ||
| RCUSArcus Biosciences, Inc. | 2.55B | 20.37 | -6.19 | -4.26% | -142.91% | -55.94% | 0.16 | |
| RLAYRelay Therapeutics, Inc. | 1.78B | 10.26 | -6.37 | 53.44% | -18.01% | -48.76% | 0.06 | |
| STROSutro Biopharma, Inc. | 1.74B | 20.47 | -6.92 | -59.64% | -205.18% | -234.19% | 4.57 | |
| OLMAOlema Pharmaceuticals, Inc. | 1.66B | 24.20 | -11 | -48.77% | 0.00 |
Analyze head-to-head performance against top industry competitors across valuation, growth, and profitability metrics.
| Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 0 | 0 | 0 | 19.54M | 27.94M | 50.93M | 23.39M | 7M | 218.71M |
| Revenue Growth % | - | - | - | - | 43.01% | 82.28% | -54.08% | -70.07% | 3024.43% |
| Cost of Goods Sold | 391K | 886K | 1.25M | 1.38M | 1.73M | 2.1M | 4.01M | 3.83M | 4.59M |
| COGS % of Revenue | - | - | - | 7.07% | 6.17% | 4.13% | 17.14% | 54.77% | 2.1% |
| Gross Profit | -391K | -886K | -1.25M | 18.16M | 26.22M | 48.83M | 19.38M | 3.17M | 214.12M |
| Gross Margin % | - | - | - | 92.93% | 93.83% | 95.87% | 82.86% | 45.23% | 97.9% |
| Gross Profit Growth % | - | -126.6% | -40.52% | 1558.39% | 44.39% | 86.26% | -60.32% | -83.66% | 6663.01% |
| Operating Expenses | 14.05M | 35.53M | 43.03M | 53.5M | 76.48M | 111.33M | 153.81M | 330.14M | 373.43M |
| OpEx % of Revenue | - | - | - | 273.83% | 273.73% | 218.59% | 657.71% | 4716.3% | 170.74% |
| Selling, General & Admin | 1.66M | 3.78M | 8.71M | 13.8M | 18.33M | 21.8M | 24.3M | 35.47M | 63.32M |
| SG&A % of Revenue | - | - | - | 70.65% | 65.59% | 42.8% | 103.9% | 506.69% | 28.95% |
| Research & Development | 12.38M | 31.75M | 34.32M | 39.7M | 58.16M | 89.54M | 129.51M | 294.67M | 314.7M |
| R&D % of Revenue | - | - | - | 203.18% | 208.15% | 175.8% | 553.81% | 4209.61% | 143.89% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.59M |
| Operating Income | -14.44M | -36.42M | -44.27M | -35.34M | -50.27M | -62.5M | -134.43M | -326.98M | -159.31M |
| Operating Margin % | - | - | - | -180.9% | -179.91% | -122.72% | -574.85% | -4671.07% | -72.84% |
| Operating Income Growth % | - | -152.23% | -21.57% | 20.16% | -42.23% | -24.34% | -115.08% | -143.23% | 51.28% |
| EBITDA | -14.05M | -35.53M | -43.03M | -33.96M | -48.54M | -60.4M | -130.42M | -323.14M | -154.72M |
| EBITDA Margin % | - | - | - | -173.83% | -173.73% | -118.59% | -557.71% | -4616.3% | -70.74% |
| EBITDA Growth % | - | -152.94% | -21.09% | 21.06% | -42.93% | -24.43% | -115.93% | -147.77% | 52.12% |
| D&A (Non-Cash Add-back) | 391K | 886K | 1.25M | 1.38M | 1.73M | 2.1M | 4.01M | 3.83M | 4.59M |
| EBIT | -11.86M | -34.35M | -41.98M | -34.49M | -49.76M | -58.66M | -112.96M | -274.48M | -159.31M |
| Net Interest Income | 150K | 1.99M | 2.29M | 849K | 506K | 3.85M | 21.47M | 52.5M | 45.62M |
| Interest Income | 150K | 1.99M | 2.29M | 849K | 506K | 3.85M | 21.47M | 52.5M | 45.62M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 2.58M | 2.07M | 2.3M | 849K | 506K | 3.85M | 21.47M | 52.5M | 45.62M |
| Pretax Income | -11.86M | -34.35M | -41.98M | -34.49M | -49.76M | -58.66M | -112.96M | -274.48M | -113.7M |
| Pretax Margin % | - | - | - | -176.55% | -178.1% | -115.17% | -483.05% | -3921.1% | -51.99% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| Net Income | -11.86M | -34.35M | -41.98M | -34.49M | -49.76M | -58.66M | -112.96M | -274.48M | -113.7M |
| Net Margin % | - | - | - | -176.55% | -178.1% | -115.17% | -483.05% | -3921.1% | -51.99% |
| Net Income Growth % | - | -189.55% | -22.21% | 17.82% | -44.26% | -17.87% | -92.59% | -142.98% | 58.58% |
| Net Income (Continuing) | -11.86M | -34.35M | -41.98M | -34.49M | -49.76M | -58.66M | -112.96M | -274.48M | -113.7M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.83 | -2.41 | -1.90 | -1.31 | -1.41 | -1.42 | -1.96 | -3.36 | -1.28 |
| EPS Growth % | - | -190.36% | 21.16% | 31.05% | -7.63% | -0.71% | -38.03% | -71.43% | 61.9% |
| EPS (Basic) | -0.83 | -2.41 | -1.90 | -1.31 | -1.41 | -1.42 | -1.96 | -3.36 | -1.28 |
| Diluted Shares Outstanding | 14.24M | 14.24M | 20.23M | 24.72M | 35.25M | 41.44M | 57.52M | 81.68M | 88.49M |
| Basic Shares Outstanding | 14.24M | 14.24M | 20.23M | 24.72M | 35.25M | 41.44M | 57.52M | 81.68M | 88.49M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
| Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 13.58M | 90.67M | 101.65M | 288.61M | 251M | 370.45M | 532.63M | 689.71M | 666.73M |
| Cash & Short-Term Investments | 13.16M | 89.96M | 98.96M | 283.58M | 246.77M | 364.83M | 525.11M | 676.32M | 639.39M |
| Cash Only | 5.96M | 20.5M | 34.07M | 72.04M | 92.05M | 68.63M | 157.02M | 84.38M | 112.83M |
| Short-Term Investments | 7.2M | 69.46M | 64.89M | 211.55M | 154.72M | 296.2M | 368.1M | 591.94M | 526.56M |
| Accounts Receivable | 0 | 0 | 0 | 1.88M | 1.1M | 211K | 18K | 3K | 0 |
| Days Sales Outstanding | - | - | - | 35.07 | 14.41 | 1.51 | 0.28 | 0.16 | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | 5.41M | 7.5M | 13.39M | 27.34M |
| Total Non-Current Assets | 3.9M | 5.87M | 11.35M | 9.66M | 130.35M | 17.52M | 116.68M | 434.38M | 442.6M |
| Property, Plant & Equipment | 3.74M | 5.15M | 9.7M | 9.48M | 8.66M | 8.99M | 8.41M | 27.74M | 31.29M |
| Fixed Asset Turnover | - | - | - | 2.06x | 3.23x | 5.66x | 2.78x | 0.25x | 6.99x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 71K | 0 | 1.53M | 0 | 121.29M | 8.32M | 107.49M | 405.83M | 0 |
| Other Non-Current Assets | 89K | 722K | 122K | 188K | 397K | 205K | 782K | 805K | 411.31M |
| Total Assets | 17.48M | 96.54M | 113M | 298.27M | 381.35M | 387.97M | 649.32M | 1.12B | 1.11B |
| Asset Turnover | - | - | - | 0.07x | 0.07x | 0.13x | 0.04x | 0.01x | 0.20x |
| Asset Growth % | - | 452.33% | 17.05% | 163.95% | 27.85% | 1.74% | 67.36% | 73.12% | -1.31% |
| Total Current Liabilities | 2.43M | 5.41M | 6.94M | 38.64M | 45.16M | 31.72M | 27.1M | 46.07M | 58.81M |
| Accounts Payable | 662K | 1.42M | 709K | 953K | 2.1M | 4.28M | 6.6M | 15.42M | 17.58M |
| Days Payables Outstanding | 617.98 | 583.75 | 207.86 | 251.88 | 444.35 | 743.55 | 600.87 | 1.47K | 1.4K |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 339K |
| Deferred Revenue (Current) | 297K | 0 | 0 | 27.61M | 29.04M | 8.57M | 0 | 0 | 0 |
| Other Current Liabilities | 728K | 413K | 63K | 18K | 0 | 0 | 11.78M | 30.35M | 40.89M |
| Current Ratio | 5.58x | 16.75x | 14.65x | 7.47x | 5.56x | 11.68x | 19.65x | 14.97x | 11.34x |
| Quick Ratio | 5.58x | 16.75x | 14.65x | 7.47x | 5.56x | 11.68x | 19.65x | 14.97x | 11.34x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 30.78M | 140.08M | 5.66M | 61.35M | 34.67M | 6.8M | 1.13M | 18.87M | 27.57M |
| Long-Term Debt | 3.21M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27.57M |
| Capital Lease Obligations | 0 | 0 | 5.63M | 5.18M | 3.48M | 1.61M | 1.13M | 18.87M | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 27.58M | 140.08M | 34K | 12K | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 33.22M | 145.49M | 12.6M | 100M | 79.83M | 38.51M | 28.23M | 64.94M | 86.39M |
| Total Debt | 3.21M | 0 | 6.77M | 6.72M | 5.18M | 3.48M | 2.87M | 19.17M | 27.91M |
| Net Debt | -2.75M | -20.5M | -27.3M | -65.31M | -86.86M | -65.15M | -154.15M | -65.21M | -84.91M |
| Debt / Equity | - | - | 0.07x | 0.03x | 0.02x | 0.01x | 0.00x | 0.02x | 0.03x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - |
| Total Equity | -15.74M | -48.95M | 100.4M | 198.27M | 301.51M | 349.45M | 621.09M | 1.06B | 1.02B |
| Equity Growth % | - | -211% | 305.12% | 97.48% | 52.07% | 15.9% | 77.73% | 70.53% | -3.42% |
| Book Value per Share | -1.11 | -3.44 | 4.96 | 8.02 | 8.55 | 8.43 | 10.80 | 12.97 | 11.56 |
| Total Shareholders' Equity | -15.74M | -48.95M | 100.4M | 198.27M | 301.51M | 349.45M | 621.09M | 1.06B | 1.02B |
| Common Stock | 1K | 0 | 2K | 3K | 4K | 5K | 7K | 9K | 9K |
| Retained Earnings | -16.17M | -50.52M | -92.49M | -126.99M | -176.75M | -235.4M | -348.36M | -622.84M | -736.54M |
| Treasury Stock | -431K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -1K | -31K | 65K | 7K | -712K | -2.87M | 562K | 812K | 2.27M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -12.22M | -27.62M | -39.31M | 55.46M | -55.78M | -87.17M | -115.22M | -247.58M | -71.1M |
| Operating CF Margin % | - | - | - | 283.87% | -199.63% | -171.16% | -492.73% | -3536.91% | -32.51% |
| Operating CF Growth % | - | -125.95% | -42.34% | 241.08% | -200.57% | -56.29% | -32.18% | -114.87% | 71.28% |
| Net Income | -11.86M | -34.35M | -41.98M | -34.49M | -49.76M | -58.66M | -112.96M | -274.48M | 0 |
| Depreciation & Amortization | 391K | 886K | 1.25M | 1.38M | 1.73M | 2.1M | 4.01M | 3.83M | 0 |
| Stock-Based Compensation | 136K | 950K | 2.17M | 3.61M | 8.24M | 11.63M | 18.49M | 34.75M | 0 |
| Deferred Taxes | -27K | -873K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -2.43M | 4.11M | -467K | 562K | 1.83M | -695K | -11.55M | -23.23M | -72.97M |
| Working Capital Changes | 1.56M | 1.65M | -284K | 84.41M | -17.81M | -41.55M | -13.21M | 11.55M | 1.87M |
| Change in Receivables | 0 | 0 | 0 | -1.88M | 774K | 892K | 193K | 15K | 0 |
| Change in Inventory | 0 | 0 | 0 | 2.29M | 3.79M | 0 | 0 | 0 | 0 |
| Change in Payables | 254K | 322K | -195K | 225K | 1.17M | 1.86M | 2.63M | 8.28M | 2.7M |
| Cash from Investing | -8.93M | -63.18M | 2.27M | -146.24M | -69.67M | -33.4M | -158.46M | -502.56M | 69.98M |
| Capital Expenditures | -1.76M | -1.71M | -1.35M | -493K | -2.64M | -3.44M | -2.37M | -3.86M | -2.37M |
| CapEx % of Revenue | - | - | - | 2.52% | 9.46% | 6.76% | 10.13% | 55.1% | 1.08% |
| Acquisitions | 0 | 0 | -8K | -18K | 67.02M | 33.4M | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 8K | 18K | -67.02M | -33.4M | 0 | 0 | 0 |
| Cash from Financing | 17.49M | 105.38M | 50.61M | 128.75M | 145.45M | 97.17M | 362.72M | 677.55M | 29.78M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 226K | 20K | 289K | 1.52M | 2.2M | 2.2M | 10.77M | 13.92M | 0 |
| Net Change in Cash | -3.66M | 14.58M | 13.56M | 37.97M | 20.01M | -23.41M | 89.04M | -72.59M | 28.45M |
| Free Cash Flow | -13.98M | -29.33M | -40.67M | 54.97M | -58.42M | -90.62M | -117.59M | -251.44M | -73.47M |
| FCF Margin % | - | - | - | 281.35% | -209.09% | -177.92% | -502.85% | -3592.01% | -33.59% |
| FCF Growth % | - | -109.77% | -38.66% | 235.17% | -206.28% | -55.11% | -29.77% | -113.82% | 70.78% |
| FCF per Share | -0.98 | -2.06 | -2.01 | 2.22 | -1.66 | -2.19 | -2.04 | -3.08 | -0.83 |
| FCF Conversion (FCF/Net Income) | 1.03x | 0.80x | 0.94x | -1.61x | 1.12x | 1.49x | 1.02x | 0.90x | 0.63x |
| Interest Paid | 0 | 99K | 91K | 82K | 71K | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 1K | 1K | 1K | 4K | 0 | 0 | 0 | 0 |
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | -163.16% | -23.1% | -19.91% | -18.02% | -23.28% | -32.67% | -10.92% |
| Return on Invested Capital (ROIC) | - | - | -1818.36% | -25.73% | -21.69% | -18.79% | -26.84% | -33.57% | -12.37% |
| Gross Margin | - | - | - | 92.93% | 93.83% | 95.87% | 82.86% | 45.23% | 97.9% |
| Net Margin | - | - | - | -176.55% | -178.1% | -115.17% | -483.05% | -3921.1% | -51.99% |
| Debt / Equity | - | - | 0.07x | 0.03x | 0.02x | 0.01x | 0.00x | 0.02x | 0.03x |
| FCF Conversion | 1.03x | 0.80x | 0.94x | -1.61x | 1.12x | 1.49x | 1.02x | 0.90x | 0.63x |
| Revenue Growth | - | - | - | - | 43.01% | 82.28% | -54.08% | -70.07% | 3024.43% |
Explore detailed financial history, valuation models, and returns analysis
DCF models, peer multiples & analyst estimates
Historical returns with dividends reinvested
Yield, growth, payout safety & DRIP calculator
EPS trends, net income & profitability analysis
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of valuation, profitability & efficiency metrics